Comparison of surgical invasiveness, hidden blood loss, and clinical outcome between unilateral biportal endoscopic and minimally invasive transforaminal lumbar interbody fusion for lumbar degenerative disease: a retrospective cohort study

Abstract Background Currently, hidden blood loss (HBL) has been paid more and more attention by spine surgeons. Simultaneously, it has been the effort of spine surgeons to explore more advantages of minimally invasive surgery. More and more articles have compared unilateral biportal endoscopic lumba...

Full description

Bibliographic Details
Main Authors: Xinle Huang, Wenkai Wang, Guangxing Chen, Xiangchen Guan, Yue Zhou, Yu Tang
Format: Article
Language:English
Published: BMC 2023-04-01
Series:BMC Musculoskeletal Disorders
Subjects:
Online Access:https://doi.org/10.1186/s12891-023-06374-1
_version_ 1797846174709841920
author Xinle Huang
Wenkai Wang
Guangxing Chen
Xiangchen Guan
Yue Zhou
Yu Tang
author_facet Xinle Huang
Wenkai Wang
Guangxing Chen
Xiangchen Guan
Yue Zhou
Yu Tang
author_sort Xinle Huang
collection DOAJ
description Abstract Background Currently, hidden blood loss (HBL) has been paid more and more attention by spine surgeons. Simultaneously, it has been the effort of spine surgeons to explore more advantages of minimally invasive surgery. More and more articles have compared unilateral biportal endoscopic lumbar interbody fusion (BE-LIF) and minimally invasive transforaminal lumbar interbody fusion (MIS-TLIF). But so far, there is no HBL comparison between BE-LIF and MIS-TLIF. This study aims to compare the surgical invasiveness, hidden blood loss, and clinical outcome of BE-LIF and MIS-TLIF and to provide insight regarding minimally invasive surgery for lumbar degenerative disease (LDD). Methods We enrolled 103 eligible patients with LDD who underwent BE-LIF (n = 46) and MIS-TLIF (n = 57) during August 2020–March 2021. We collected data, including demographics, perioperative haematocrit, operative and postoperative hospital times, serum creatine kinase (CK) and C-reactive protein (CRP) levels, and hospitalization costs. Total and hidden blood loss was calculated. Clinical outcomes were assessed using a visual analogue scale (VAS) score for back and leg pain, Oswestry Disability Index (ODI), modified MacNab criteria, fusion rate, and complications. Results Basic demographics and surgical data were comparable. The CRP and CK levels were generally lower in the BE-LIF than in the MIS-TLIF group, especially CRP levels on postoperative day (POD) three and CK levels on POD one. True total blood loss, postoperative blood loss, and hidden blood loss were significantly reduced in the BE-LIF group compared with the MIS-TLIF group. Postoperative hospital times was statistically significantly shorter in the BE-LIF group. The VAS pain and ODI scores improved in both groups. At three days and one month, the VAS lower back pain scores were significantly better after BE-LIF. Clinical outcomes did not otherwise differ between groups. Conclusions Compared with MIS-TLIF, BE-LIF has similar medium and short-term clinical outcomes. However, it is better regarding surgical trauma, early lower back pain, total and hidden blood loss, and recovery time. BE-LIF is an adequate option for selected LDD.
first_indexed 2024-04-09T17:50:39Z
format Article
id doaj.art-a1bf192afa824b5c8c4961917c7fc6b1
institution Directory Open Access Journal
issn 1471-2474
language English
last_indexed 2024-04-09T17:50:39Z
publishDate 2023-04-01
publisher BMC
record_format Article
series BMC Musculoskeletal Disorders
spelling doaj.art-a1bf192afa824b5c8c4961917c7fc6b12023-04-16T11:04:36ZengBMCBMC Musculoskeletal Disorders1471-24742023-04-0124111010.1186/s12891-023-06374-1Comparison of surgical invasiveness, hidden blood loss, and clinical outcome between unilateral biportal endoscopic and minimally invasive transforaminal lumbar interbody fusion for lumbar degenerative disease: a retrospective cohort studyXinle Huang0Wenkai Wang1Guangxing Chen2Xiangchen Guan3Yue Zhou4Yu Tang5Department of Orthopaedics, The Second Affiliated Xinqiao Hospital of Army Medical UniversityDepartment of Orthopaedics, The Second Affiliated Xinqiao Hospital of Army Medical UniversityCenter for Joint Surgery, Southwest Hospital, Army Medical UniversityDepartment of Orthopaedics, The Second Affiliated Xinqiao Hospital of Army Medical UniversityDepartment of Orthopaedics, The Second Affiliated Xinqiao Hospital of Army Medical UniversityDepartment of Orthopaedics, The Second Affiliated Xinqiao Hospital of Army Medical UniversityAbstract Background Currently, hidden blood loss (HBL) has been paid more and more attention by spine surgeons. Simultaneously, it has been the effort of spine surgeons to explore more advantages of minimally invasive surgery. More and more articles have compared unilateral biportal endoscopic lumbar interbody fusion (BE-LIF) and minimally invasive transforaminal lumbar interbody fusion (MIS-TLIF). But so far, there is no HBL comparison between BE-LIF and MIS-TLIF. This study aims to compare the surgical invasiveness, hidden blood loss, and clinical outcome of BE-LIF and MIS-TLIF and to provide insight regarding minimally invasive surgery for lumbar degenerative disease (LDD). Methods We enrolled 103 eligible patients with LDD who underwent BE-LIF (n = 46) and MIS-TLIF (n = 57) during August 2020–March 2021. We collected data, including demographics, perioperative haematocrit, operative and postoperative hospital times, serum creatine kinase (CK) and C-reactive protein (CRP) levels, and hospitalization costs. Total and hidden blood loss was calculated. Clinical outcomes were assessed using a visual analogue scale (VAS) score for back and leg pain, Oswestry Disability Index (ODI), modified MacNab criteria, fusion rate, and complications. Results Basic demographics and surgical data were comparable. The CRP and CK levels were generally lower in the BE-LIF than in the MIS-TLIF group, especially CRP levels on postoperative day (POD) three and CK levels on POD one. True total blood loss, postoperative blood loss, and hidden blood loss were significantly reduced in the BE-LIF group compared with the MIS-TLIF group. Postoperative hospital times was statistically significantly shorter in the BE-LIF group. The VAS pain and ODI scores improved in both groups. At three days and one month, the VAS lower back pain scores were significantly better after BE-LIF. Clinical outcomes did not otherwise differ between groups. Conclusions Compared with MIS-TLIF, BE-LIF has similar medium and short-term clinical outcomes. However, it is better regarding surgical trauma, early lower back pain, total and hidden blood loss, and recovery time. BE-LIF is an adequate option for selected LDD.https://doi.org/10.1186/s12891-023-06374-1Unilateral biportal endoscopyLumbar interbody fusionLumbar degenerative diseasesHidden blood loss
spellingShingle Xinle Huang
Wenkai Wang
Guangxing Chen
Xiangchen Guan
Yue Zhou
Yu Tang
Comparison of surgical invasiveness, hidden blood loss, and clinical outcome between unilateral biportal endoscopic and minimally invasive transforaminal lumbar interbody fusion for lumbar degenerative disease: a retrospective cohort study
BMC Musculoskeletal Disorders
Unilateral biportal endoscopy
Lumbar interbody fusion
Lumbar degenerative diseases
Hidden blood loss
title Comparison of surgical invasiveness, hidden blood loss, and clinical outcome between unilateral biportal endoscopic and minimally invasive transforaminal lumbar interbody fusion for lumbar degenerative disease: a retrospective cohort study
title_full Comparison of surgical invasiveness, hidden blood loss, and clinical outcome between unilateral biportal endoscopic and minimally invasive transforaminal lumbar interbody fusion for lumbar degenerative disease: a retrospective cohort study
title_fullStr Comparison of surgical invasiveness, hidden blood loss, and clinical outcome between unilateral biportal endoscopic and minimally invasive transforaminal lumbar interbody fusion for lumbar degenerative disease: a retrospective cohort study
title_full_unstemmed Comparison of surgical invasiveness, hidden blood loss, and clinical outcome between unilateral biportal endoscopic and minimally invasive transforaminal lumbar interbody fusion for lumbar degenerative disease: a retrospective cohort study
title_short Comparison of surgical invasiveness, hidden blood loss, and clinical outcome between unilateral biportal endoscopic and minimally invasive transforaminal lumbar interbody fusion for lumbar degenerative disease: a retrospective cohort study
title_sort comparison of surgical invasiveness hidden blood loss and clinical outcome between unilateral biportal endoscopic and minimally invasive transforaminal lumbar interbody fusion for lumbar degenerative disease a retrospective cohort study
topic Unilateral biportal endoscopy
Lumbar interbody fusion
Lumbar degenerative diseases
Hidden blood loss
url https://doi.org/10.1186/s12891-023-06374-1
work_keys_str_mv AT xinlehuang comparisonofsurgicalinvasivenesshiddenbloodlossandclinicaloutcomebetweenunilateralbiportalendoscopicandminimallyinvasivetransforaminallumbarinterbodyfusionforlumbardegenerativediseasearetrospectivecohortstudy
AT wenkaiwang comparisonofsurgicalinvasivenesshiddenbloodlossandclinicaloutcomebetweenunilateralbiportalendoscopicandminimallyinvasivetransforaminallumbarinterbodyfusionforlumbardegenerativediseasearetrospectivecohortstudy
AT guangxingchen comparisonofsurgicalinvasivenesshiddenbloodlossandclinicaloutcomebetweenunilateralbiportalendoscopicandminimallyinvasivetransforaminallumbarinterbodyfusionforlumbardegenerativediseasearetrospectivecohortstudy
AT xiangchenguan comparisonofsurgicalinvasivenesshiddenbloodlossandclinicaloutcomebetweenunilateralbiportalendoscopicandminimallyinvasivetransforaminallumbarinterbodyfusionforlumbardegenerativediseasearetrospectivecohortstudy
AT yuezhou comparisonofsurgicalinvasivenesshiddenbloodlossandclinicaloutcomebetweenunilateralbiportalendoscopicandminimallyinvasivetransforaminallumbarinterbodyfusionforlumbardegenerativediseasearetrospectivecohortstudy
AT yutang comparisonofsurgicalinvasivenesshiddenbloodlossandclinicaloutcomebetweenunilateralbiportalendoscopicandminimallyinvasivetransforaminallumbarinterbodyfusionforlumbardegenerativediseasearetrospectivecohortstudy